Shook FDA Attorney To Moderate Panel on Animal Biotechnology

Shook FDA Regulatory Of Counsel Kristin Kaplan will be moderating the session “Animal Biotechnology: The Legal and Regulatory Challenges and Opportunities of Gene Edited Animals,” June 14, 3:15–4:15 p.m. ET, at the FDLI Annual Conference in Washington, D.C. The panel will discuss FDA guidance regarding the regulation of intentionally genomic alterations (IGA) in animals and the approval of the first IGA, GalSafe pigs, as a source for human food consumption and potential therapeutic uses. Also in the discussion: legal and regulatory challenges IGA product industries may encounter and promising uses of these products from both the biomedical and agricultural perspectives.

Kaplan is a recognized leader in FDA regulatory practice. Before joining Shook, Kaplan was the deputy general counsel in charge of global regulatory legal support and litigation at an animal health company and was an associate chief counsel for FDA.